CDT Buys Light-emitting Dendrimer Business
CDT receives ownership of all rights to Opsys' dendrimer OLED technology and assumes management of the commercial and technical development of Opsys' business. More than 25 highly-skilled scientists from Opsys have been added to CDT's staff.Financial terms of the agreement include an immediate payment in cash and deferred payment in CDT shares. Opsys' US business is not part of the agreement and retains privileged rights to use dendrimers and other technologies developed by Opsys.Toppan Printing of Japan - an investor in Opsys - will invest in CDT as a major corporate shareholder and partner. Toppan will also convert its existing shareholding in Opsys into an equivalent holding in CDT. The joint development work begun with Opsys will be transferred to CDT.CDT and Opsys have been developing organic display technology for electronic displays and lighting applications. Both companies were founded on fundamental research undertaken at UK universities - CDT in 1992 from the University of Cambridge and Opsys in 1997 from the University of Oxford.
